Embodiments of the present application relate to batches of bupivacaine multivesicular liposomes (MVLs) prepared by a commercial manufacturing process using independently operating dual tangential flow filtration modules.

Embodiments of the present application relate to batches of bupivacaine multivesicular liposomes (MVLs) prepared by a commercial manufacturing process using independently operating dual tangential flow filtration modules.

The present subject matter further relates to a box-type portable flow rate metering device for measuring flow rate of multiple fluids of varied viscosities while being supplies to form a final mixture. The device includes a flow meter which is detachably arranged per feed line to measure a flow rate of respective fluid during each operation cycle; and a digital display unit coupled to the respective flow meter to display the flow rate of the respective fluid during each operation cycle.

Conventional ozone water is still insufficient in the removal rate and cleaning ability of resist required in today's semiconductor manufacturing field, and it does not fully meet the expectation of further improvement in the effects of sterilization, deodorization, and cleaning in the fields such as cleaning of foodstuffs, cleaning of process equipment and tools, and cleaning of fingers, as well as in the fields such as deodorization, sterilization, and preservation of freshness of foodstuffs. The above problem can be solved by defining the values of a plurality of specific production parameters in the production of ozone water into specific ranges.

Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

A fluid handling apparatus for ejecting fluid into a tank and draining fluid from the tank comprises: a fluid duct for draining/supplying fluid from/to the tank, the fluid duct configured for fluid communication with a tank opening at a tank bottom; a fluid inlet pipe for supplying fluid to the tank, the fluid inlet pipe extending at least partly through the fluid duct and configured to extend through the tank opening into the tank; a rotary fluid ejection device in fluid communication with the fluid inlet pipe; and a rotary drive shaft extending at least partly inside the fluid inlet pipe, the rotary drive shaft being rotatably connected to the rotary fluid ejection device. Also disclosed is a fluid tank system comprising a tank and a fluid handling apparatus, and a method for mixing beer or wort with solid hops material in a tank by a fluid handling apparatus.

A mixing and dispensing device and method. In particular, the device used by the applied method reduces the risk of chlorine gas formation while providing a stable, effective and safe disinfectant in the form of a hypochlorous add and sodium hypochlorite mixture. The mixing and dispensing device includes a highly concentrated disinfectant and dilutes the concentrate through the device while simultaneously mixing the concentrate with a dilute solution of an organic acid. The two diluted solutions are mixed without production of chlorine gas and to a level of safety before being dispensed to produce the stable, effective and safe neutral pH sodium hypochlorite solution disinfectant in the form of a hypochlorous add and sodium hypochlorite mixture. The mixing and dispensing device can be in the form of a kit for retrofitting into institutions or isolated, remote areas in need thereof or for off the shelf use in the home.

Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.